Delivery Order SPE2DB20D3505-SPE2DB22FU1A7
- Not listed
- This federal contract award, valued at $4,464.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,557,446,490 units of the prescription drug Lisinopril-HCTZ 20-25 mg tablets. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 90-count bottles of the 20 mg lisinopril tablet. The $2,220.25 firm fixed-price delivery order falls under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a ceiling value of $1,150.62. The contract is for a fixed price and has an ultimate completion date of June 24, 2025. The contract is not set aside for any specific small business designation. AmerisourceBergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,989.87, is a delivery order for Lisinopril 10 mg tablets. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $9,085.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of 4,565,079,360 tablets of Lisinopril 10 mg, a common cardiovascular medication. The contract has an ultimate completion date of July 8, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
- This award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-12.5 mg tablets, with a firm fixed price of $1,126.61 and a performance period through May 13, 2025. The contract is not set aside for any small business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,661.04 firm fixed-price delivery order is for the supply of 4564374289 - Lisinopril-HCTZ 20-12.5 mg Tablets, 500 count. The award does not have a set-aside designation. AmerisourceBergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025. This contract...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $6,524.03 delivery order contract is for the supply of Lisinopril 20 mg tablets, a cardiovascular medication. The contract has a period of performance through January 20, 2022 and utilizes a firm fixed price pricing structure. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger $999,999,999...
- This federal contract award is for the delivery of Lisinopril-HCTZ 20-25 mg tablets in 90-count packages to the Defense Logistics Agency (DLA). The award, valued at $1,062.00, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a firm fixed price and an ultimate completion date of April 26, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the military and...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FU1A7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-25 mg. The single-award, firm-fixed price delivery order, valued at $2,066.47, has a completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This delivery order represents one of the many pharmaceutical items AmerisourceBergen supplies to the DLA under its IDC. The contract did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/27/22 |